THYMULIN, ZINC AND INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ACTIVITY BEFORE AND DURING RECOMBINANT GROWTH-HORMONE (REC-GH) THERAPY IN CHILDREN AND ADULTS WITH GH DEFICIENCY
E. Mocchegiani et al., THYMULIN, ZINC AND INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) ACTIVITY BEFORE AND DURING RECOMBINANT GROWTH-HORMONE (REC-GH) THERAPY IN CHILDREN AND ADULTS WITH GH DEFICIENCY, Journal of endocrinological investigation, 19(9), 1996, pp. 630-637
Plasma thymulin (active and total) levels, IGF-I and zinc concentratio
ns were evaluated in 9 children and in 8 adults with GH deficiency (GH
D) before and after 3-6 months of recombinant-GH treatment. Before the
rapy, GH deficient children had lower plasma active thymulin levels (1
.0+/-0.3 log(-2)), not due to a peripheral defect in zinc saturation s
ince plasma zinc levels were within the normal range, and total thymul
in levels (1.3+/-0.3 log(-2)) than in the agematched control group. GH
therapy significantly increased active thymulin (3rd month: 3.0+/-0.2
log(-2), 6th month: 4.0+/-0.2 log(-2)), total thymulin (3rd month: 3.
3+/-0.3 log(-2), 6th month: 4.3+/-0.2 log(-2)) and IGF-I levels (3rd m
onth: 283.3+/-7.2 mu g/L, 6th month: 411.2+/-44.2 mu g/L, vs basal: 14
4.3+/-11.5 mu g/L); at the 6th month of therapy, thymulin levels (acti
ve and total) were comparable to those found in controls. A positive c
orrelation existed between zinc and plasma IGF-I levels (r=0.66, p<0.0
5). In adults with GHD, plasma active (1.9+/-0.3 log(-2)) and total th
ymulin levels (3.9+/-0.1 log(-2)), significantly lower (p<0.01 and 0.0
5, respectively) than in controls before treatment, increased after GH
therapy (active thymulin, 3rd month: 3.0+/-0.2 log(-2), 6th month: 4.
4+/-0.3 log(-2); total thymulin, 3rd month: 3.9+/-0.3 log(-2), 6th mon
th: 4.71+/-0.2 log(-2)), being at 6th month of therapy no more differe
nt from the values recorded in the age-matched control group. In concl
usion, children and adults with GHD have a marked impairment of the th
ymic endocrine activity, which can be restored by six months of GH tre
atment. The effects of GH on thymic functions may be mediated by IGF-I
, through the modulation of zinc turnover, suggesting the possible exi
stence of an interplay among GH, zinc, IGF-I and thymulin both in chil
dren and adults with GHD. (C) 1996, Editrice Kurtis